Article Versions Notes

Benslimane N, Loret C, Chazelas P, Favreau F, Faye P-A, Lejeune F, Lia A-S. Readthrough Activators and Nonsense-Mediated mRNA Decay Inhibitor Molecules: Real Potential in Many Genetic Diseases Harboring Premature Termination Codons. Pharmaceuticals. 2024; 17(3):314. https://doi.org/10.3390/ph17030314

Benslimane, Nesrine, Camille Loret, Pauline Chazelas, Frédéric Favreau, Pierre-Antoine Faye, Fabrice Lejeune, and Anne-Sophie Lia. 2024. "Readthrough Activators and Nonsense-Mediated mRNA Decay Inhibitor Molecules: Real Potential in Many Genetic Diseases Harboring Premature Termination Codons" Pharmaceuticals 17, no. 3: 314. https://doi.org/10.3390/ph17030314

Benslimane, N., Loret, C., Chazelas, P., Favreau, F., Faye, P.-A., Lejeune, F., & Lia, A.-S. (2024). Readthrough Activators and Nonsense-Mediated mRNA Decay Inhibitor Molecules: Real Potential in Many Genetic Diseases Harboring Premature Termination Codons. Pharmaceuticals, 17(3), 314. https://doi.org/10.3390/ph17030314